65110-19-2

Upstream product

• 4346-94-5 thiosemicarbazide hydrochloride 
• 94-02-0 ethyl 3-oxo-3-phenylpropionate 
• 79-19-6 thiosemicarbazide 

Downstream Products

• 953793-91-4 CH₃COO^(1-)*C₃HN₂O(C₆H₅)CSNH₂^(1-)*Pb⁽²⁺⁾=Pb(C₃HN₂O(C₆H₅)CSNH₂)(CH₃COO) 
• 314761-14-3 (Z)-5-phenyl-2-(4-phenylthiazol-2-yl)-4-(2-(thiazol-2-yl)-hydrazono)-2,4-dihydro-3H-pyrazol-3-one 
• 873778-85-9 [Zn(H₂NC(S)NNC(C₆H₅)CHC(O))2]*CH₃OH 

Relevant academic research and scientific papers

BAX ACTIVATORS AND USES THEREOF IN CANCER THERAPY

Activators of BAX and their uses in cancer therapy are disclosed.

M-STAGE KINESIN INHIBITOR

A mitotic kinesin Eg5 inhibitor which comprises a thiadiazoline derivative represented by the general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient: [wherein R1 represents a hydrogen atom and the like, R2 represents a hydrogen atom, -C(=W)R6 (wherein W represents an oxygen atom or a sulfur atom, and R6 represents substituted or unsubstituted lower alkyl and the like) and the like, R3 represents -C(=Z)R19 (wherein Z represents an oxygen atom or a sulfur atom, and R19 represents substituted or unsubstituted lower alkyl and the like) and the like, R4 represents substituted or unsubstituted lower alkyl and the like, and R5 represents substituted or unsubstituted aryl and the like] and the like are provided.